Results from a collaborative project between Tiamat Sciences and BIOMILQ women-owned biotechnology startups in Research Triangle Park show the promise of using plant-based proteins to lower the cost of producing food using cultured cells.
Grifols, a global leader in plasma medicines, has received approval from the U.S. Food and Drug Administration for its new immunoglobulin (Ig) purification and filling facility at its Clayton manufacturing campus, one of the world’s largest sites for producing plasma-derived medicines.
North Carolina State University is bolstering its global reach through an expanded partnership for biotechnology research and education with the Technical University of Denmark Here are the details.
RESEARCH TRIANGLE PARK - A publicly traded clinical research and testing company, Science 37, will be moving its headquarters to Morrisville, creating some 250
Image by Peggy und Marco Lachmann-Anke from Pixabay
by Jim Shamp, NCBiotech Writer May 27, 2021 .
RESEARCH TRIANGLE PARK – Research Triangle Park regenerative wound-healing product developer Merakris Therapeutics is launching human testing of a liquid to treat open sores on the skin known as non-healing venous stasis ulcers (VSUs).
Merakris has received U.S. Food and Drug Administration clearance for a Phase 2 clinical trial to test its investigational therapy, Dermacyte Amniotic Wound Care Liquid. The study will address the drug’s frequency of administration, safety and efficacy.
Merakris
CEO Chris Broderick said the team at Merakris – which includes experts in regulatory affairs, good clinical practices, clinical data management, and clinical trial design and oversight – will manage the study. It will work with a Good Manufacturing Practices laboratory partner to ensure that the investigational product is manufactured in accordance with all FDA requirements.